GlassScriptPhysician profile
Melanie Lee Wu
NPI 1215357223
$10,899.69
in general payments reported to CMS, 2019-2025
43 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,505 · 2020: $1,562 · 2021: $1,277 · 2022: $3,897 · 2023: $1,179 · 2024: $974 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573 · Travel and Lodging: $86.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,573.04 |
| Travel and Lodging | $86.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,769.62 | 2019-2025 | Vercise, General - Dbs, Suretek |
| Medtronic USA, INC. | $1,433.49 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $1,404.98 | 2020-2024 | Austedo, Austedo Xr |
| Abbvie INC. | $879.14 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Novartis Pharmaceuticals Corporation | $438.79 | 2020-2024 | |
| Neurocrine Biosciences, INC. | $428.87 | 2019-2025 | Ingrezza, Ongentys |
| Medtronic, INC. | $424.13 | 2021-2024 | Percept PC Brainsense |
| Abbott Laboratories | $398.64 | 2019-2024 | Infinity, Aveir |
| Acadia Pharmaceuticals INC | $397.39 | 2019-2024 | Nuplazid |
| Biogen, INC. | $273.23 | 2020-2022 | |
| Allergan, INC. | $178.24 | 2020-2021 | |
| Ucb, INC. | $172.03 | 2019-2022 | |
| Merz North America, INC. | $161.55 | 2019 | |
| Adamas Pharmaceuticals, INC. | $155.18 | 2019-2020 | |
| Neurelis, INC. | $103.04 | 2023-2024 | Valtoco |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.